Two Sigma Advisers’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-100,726
| Closed | -$6.83M | – | 2544 |
|
|
2019
Q3 | $6.83M | Sell |
100,726
-132,120
| -57% | -$8.96M | 0.02% | 662 |
|
|
2019
Q2 | $13.5M | Buy |
232,846
+84,200
| +57% | +$4.9M | 0.03% | 510 |
|
|
2019
Q1 | $10.4M | Buy |
148,646
+79,900
| +116% | +$5.6M | 0.03% | 586 |
|
|
2018
Q4 | $4.43M | Buy |
68,746
+34,072
| +98% | +$2.19M | 0.01% | 842 |
|
|
2018
Q3 | $2.44M | Sell |
34,674
-33,800
| -49% | -$2.37M | 0.01% | 1135 |
|
|
2018
Q2 | $3.45M | Buy |
68,474
+10,600
| +18% | +$534K | 0.01% | 1032 |
|
|
2018
Q1 | $1.81M | Sell |
57,874
-15,526
| -21% | -$486K | ﹤0.01% | 1288 |
|
|
2017
Q4 | $2.51M | Sell |
73,400
-18,874
| -20% | -$645K | 0.01% | 1139 |
|
|
2017
Q3 | $2.96M | Sell |
92,274
-11,400
| -11% | -$366K | 0.01% | 1020 |
|
|
2017
Q2 | $3.38M | Sell |
103,674
-12,300
| -11% | -$400K | 0.01% | 933 |
|
|
2017
Q1 | $3.65M | Sell |
115,974
-20,159
| -15% | -$635K | 0.01% | 954 |
|
|
2016
Q4 | $4M | Sell |
136,133
-20,186
| -13% | -$593K | 0.02% | 831 |
|
|
2016
Q3 | $4.52M | Buy |
156,319
+55,999
| +56% | +$1.62M | 0.02% | 685 |
|
|
2016
Q2 | $2.6M | Buy |
100,320
+400
| +0.4% | +$10.4K | 0.01% | 768 |
|
|
2016
Q1 | $2.48M | Buy |
99,920
+10,147
| +11% | +$251K | 0.01% | 722 |
|
|
2015
Q4 | $3.16M | Buy |
89,773
+52,653
| +142% | +$1.85M | 0.02% | 595 |
|
|
2015
Q3 | $792K | Buy |
37,120
+1,300
| +4% | +$27.7K | 0.01% | 1113 |
|
|
2015
Q2 | $995K | Buy |
35,820
+4,400
| +14% | +$122K | 0.01% | 1125 |
|
|
2015
Q1 | $960K | Buy |
31,420
+800
| +3% | +$24.4K | 0.01% | 1092 |
|
|
2014
Q4 | $979K | Buy |
30,620
+8,400
| +38% | +$269K | 0.01% | 1074 |
|
|
2014
Q3 | $629K | Buy |
22,220
+3,800
| +21% | +$108K | ﹤0.01% | 1109 |
|
|
2014
Q2 | $505K | Buy |
+18,420
| New | +$505K | ﹤0.01% | 1355 |
|